Stay updated on Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    ClinicalTrials.gov updated the page’s displayed revision/version from v3.5.2 to v3.5.3, without any accompanying change to the underlying study information.
    Difference
    0.1%
    Check dated 2026-04-24T05:52:36.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:29:31.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T04:47:46.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces v3.4.2 on the page.
    Difference
    0.1%
    Check dated 2026-03-12T00:00:49.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Added related topics: Ovarian cancer and MedlinePlus Genetics.
    Difference
    0.2%
    Check dated 2026-02-25T20:04:36.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Related topic tags 'Ovarian cancer' and 'MedlinePlus Genetics' were removed from the study record's metadata. This changes how the page is categorized and surfaced in topic-based searches.
    Difference
    0.2%
    Check dated 2026-02-18T16:41:35.000Z thumbnail image

Stay in the know with updates to Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.